Filing search / Lineage Cell Therapeutics, Inc. / "Charity"

424B5

LCTX Lineage Cell Therapeutics, Inc.

22 Mar 24

Prospectus supplement for primary offering

4:32pm

UK, the world’s largest independent cancer research charity. In addition to seeking to create value for shareholders by developing product candidates

424B5

LCTX Lineage Cell Therapeutics, Inc.

6 Feb 24

Prospectus supplement for primary offering

9:25am

trial is being funded and conducted by Cancer Research UK, the world’s largest independent cancer research charity. In addition to seeking to create

424B5

LCTX Lineage Cell Therapeutics, Inc.

21 Dec 21

Prospectus supplement for primary offering

6:05am

, the world’s largest independent cancer research charity. In addition to seeking to create value for shareholders by developing product candidates and other … . This clinical trial is being funded and conducted by Cancer Research UK, the world’s largest independent cancer research charity. Ownership in Other Companies

424B5

fsa7bximdjwj7

5 Mar 21

Prospectus supplement for primary offering

5:15pm

8-K/A

EX-99.2

8mc enlxutv9

25 Apr 19

Financial Statements and Exhibits

4:31pm